RT40 40mg*10vials

Retatrutide RT40 40mg*10vials

Retatrutide is a triple-receptor agonist peptide that simultaneously activates GLP-1, GIP, and glucagon receptors, representing a high-concentration metabolic research compound.

The 40mg single-vial specification offers an industry-leading active ingredient load per vial. This formulation is designed for ultra-long-term large animal models, ultra-high-dose efficacy comparison studies, and large-scale long-term laboratory projects. The high concentration per vial significantly reduces the number of vials needed for extended experiments, minimizing handling variables and operational errors from repeated dilutions.

Dual GLP-1 and GIP pathway activation supports in-depth research into insulin sensitivity, glycemic regulation, and appetite-related signaling. The glucagon receptor component adds energy expenditure and lipid metabolism research dimensions to the metabolic study scope.

This product is supplied as sterile lyophilized powder in glass vials, prepared for reconstitution with bacteriostatic water. Each batch undergoes rigorous purity testing, with a complete certificate of analysis provided.

10 vials per pack, designed for leading-edge preclinical research and large-scale scientific projects.